Literature DB >> 6440953

The syndrome of continuous muscle fibre activity following gold therapy.

W Grisold, B Mamoli.   

Abstract

A 72-year-old man suffering from arthritis received a total dose of 500 mg sodium aurothiomalate during a period of 5 months. His clinical state then deteriorated and he had to be hospitalized. Upon admission he was bedridden, his level of consciousness was slightly impaired, he was confused and respiration was laboured. Continuous muscle activity was noted on all extremities and at first, erroneously, fasciculations were diagnosed. The EMG exhibited continuous muscle fibre activity consisting of duplets, triplets and multiplets. The discharges occurred in an irregular pattern; when various muscles were examined at the same time no synchronicity could be observed between muscle discharges. In the left m. deltoideus an increased percentage of polyphasic potentials was found, whereas mean duration of motor unit potentials was normal. Spontaneous activity remained unchanged during sleep and administration of intravenous diazepam or phenytoin. Blocking of ulnar nerve at either elbow or wrist level did not stop spontaneous activity in m. abductor digiti quinti. Ischaemia increased the amount of discharges after 7 min. Within 4 months after termination of gold therapy the patient's condition improved and he was discharged from hospital. Regular EMG follow-up after 8 months showed complete cessation of abnormal spontaneous activities. Nerve conduction velocities were normal except for markedly reduced compound action potential in peroneal nerves. Continuous muscle fibre activity as a side-effect of gold therapy is described.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440953     DOI: 10.1007/bf00313659

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

1.  [Nervous complications of gold therapy; survey of the neurological and psychiatric symptoms; results of treatment with BAL].

Authors:  L J ENDTZ
Journal:  Rev Neurol (Paris)       Date:  1958-09       Impact factor: 2.607

2.  A syndrome characterized by myokymia, myotonia, muscular wasting and increased perspiration.

Authors:  I GAMSTORP; G WOHLFART
Journal:  Acta Psychiatr Neurol Scand       Date:  1959

3.  Generalised myokymia in thyrotoxicosis report of a case.

Authors:  J B HARMAN; A T RICHARDSON
Journal:  Lancet       Date:  1954-09-04       Impact factor: 79.321

4.  [Not Available].

Authors:  R C BEHREND
Journal:  Dtsch Z Nervenheilkd       Date:  1949

5.  A SYNDROME OF CONTINUOUS MUSCLE-FIBRE ACTIVITY.

Authors:  H Isaacs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-11       Impact factor: 10.154

6.  Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin.

Authors:  W E Wallis; A Van Poznak; F Plum
Journal:  Arch Neurol       Date:  1970-05

7.  Gold neuropathy.

Authors:  J C Walsh
Journal:  Neurology       Date:  1970-05       Impact factor: 9.910

8.  A dominantly inherited syndrome with continuous motor neuron discharges.

Authors:  T Ashizawa; I J Butler; Y Harati; S M Roongta
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

9.  Myokymia and facial contracture in brain stem tuberculoma. A clinicopathologic report.

Authors:  D Boghen; R Filiatrault; L Descarries
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more
  4 in total

1.  Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.

Authors:  Sudheeran Kannoth; Vivek Nambiar; Siby Gopinath; Anandkumar Anandakuttan; Annamma Mathai; Parvathy Kanjiramana Rajan
Journal:  Neurol Sci       Date:  2017-12-20       Impact factor: 3.307

2.  A Case of Hemi-Isaac's Syndrome.

Authors:  Snigdha Komakulu; Pranjal Gupta; Abhishek Anand; Animesh Das; Awadh Kishor Pandit; Achal Kumar Srivastava
Journal:  Mov Disord Clin Pract       Date:  2021-08-26

3.  Expanding Mad Hatter's Shakes: Peripheral Nerve Hyperexcitability Syndrome with Artefactual-Looking Lung Lesions.

Authors:  Ayush Agarwal; Ayush M Makkar; Venugopalan Y Vishnu; Anu Gupta; Roopa Rajan; Mamta B Singh; Rohit Bhatia; M V Padma Srivastava
Journal:  Ann Indian Acad Neurol       Date:  2020-10-07       Impact factor: 1.383

4.  Mercury Toxicity Following Unauthorized Siddha Medicine Intake - A Mimicker of Acquired Neuromyotonia - Report of 32 Cases.

Authors:  G Gnanashanmugam; R Balakrishnan; S P Somasundaram; N Parimalam; P Rajmohan; M B Pranesh
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.